amrinone has been researched along with Pancytopenia in 1 studies
Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.
Pancytopenia: Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.
Excerpt | Relevance | Reference |
---|---|---|
"The incidence of amrinone-induced thrombocytopenia has been reported to be 2." | 7.68 | Pancytopenia secondary to short-term, high-dose intravenous infusion of amrinone. ( Burnette, PK; Manny, RP; Mattingly, PM; Weston, MW, 1990) |
"The incidence of amrinone-induced thrombocytopenia has been reported to be 2." | 3.68 | Pancytopenia secondary to short-term, high-dose intravenous infusion of amrinone. ( Burnette, PK; Manny, RP; Mattingly, PM; Weston, MW, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mattingly, PM | 1 |
Burnette, PK | 1 |
Weston, MW | 1 |
Manny, RP | 1 |
1 other study available for amrinone and Pancytopenia
Article | Year |
---|---|
Pancytopenia secondary to short-term, high-dose intravenous infusion of amrinone.
Topics: Amrinone; Bone Marrow; Dopamine; Heart Failure; Humans; Hypotension; Infusions, Intravenous; Male; M | 1990 |